Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard; 2021. Available from: www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed July 19, 2021.
   Google Scholar
• Hariri L, Hardin CC. COVID-19, angiogenesis, and ARDS endotypes. N Engl J Med. 2020;383(2):182–183. doi:10.1056/NEJMe2018629
   PubMed Web of Science ®Google Scholar
• Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142(17):1609–1611. doi:10.1161/CIRCULATIONAHA.120.050354
   PubMed Web of Science ®Google Scholar
• Nagashima S, Mendes MC, Camargo Martins AP, et al. Endothelial dysfunction and thrombosis in patients with COVID-19-brief report. Arterioscler Thromb Vasc Biol. 2020;40(10):2404–2407. doi:10.1161/ATVBAHA.120.314860
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. doi:10.1016/S2352-3026(20)30216-7
   PubMed Web of Science ®Google Scholar
• Li L, Huang M, Shen J, et al. Serum levels of soluble platelet endothelial cell adhesion molecule 1 in COVID-19 patients are associated with disease severity. J Infect Dis. 2021;223(1):178–179. doi:10.1093/infdis/jiaa642
   PubMed Web of Science ®Google Scholar
• Tong M, Jiang Y, Xia D, et al. Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients. J Infect Dis. 2020;222(6):894–898. doi:10.1093/infdis/jiaa349
   PubMed Web of Science ®Google Scholar
• Syed F, Li W, Relich RF, et al. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. J Infect Dis. 2021;224(1):60–69. doi:10.1093/infdis/jiab167
   PubMed Web of Science ®Google Scholar
• Luo Q, Yan X, Tu H, Yin Y, Cao J. Progranulin aggravates pulmonary immunopathology during influenza virus infection. Thorax. 2019;74(3):305–308. doi:10.1136/thoraxjnl-2018-211916
   PubMed Web of Science ®Google Scholar
• Zou S, Luo Q, Song Z, et al. Contribution of progranulin to protective lung immunity during bacterial pneumonia. J Infect Dis. 2017;215(11):1764–1773. doi:10.1093/infdis/jix197
   PubMed Web of Science ®Google Scholar
• Gong Y, Zhan T, Li Q, et al. Serum progranulin levels are elevated in patients with chronic hepatitis B virus infection, reflecting viral load. Cytokine. 2016;85:26–29. doi:10.1016/j.cyto.2016.05.026
   PubMed Web of Science ®Google Scholar
• Wei F, Jiang Z, Sun H, et al. Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling. PLoS Pathog. 2019;15(10):e1008062. doi:10.1371/journal.ppat.1008062
   PubMed Web of Science ®Google Scholar
• Suh HS, Lo Y, Choi N, Letendre S, Lee SC. Evidence of the innate antiviral and neuroprotective properties of progranulin. PLoS One. 2014;9(5):e98184. doi:10.1371/journal.pone.0098184
   PubMed Web of Science ®Google Scholar
• Song Z, Zhang X, Zhang L, et al. Progranulin plays a central role in host defense during sepsis by promoting macrophage recruitment. Am J Respir Crit Care Med. 2016;194(10):1219–1232. doi:10.1164/rccm.201601-0056OC
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu Y, Yang M, Zhang M, Xiao M, Li X. Butyrate mitigates TNF-α-induced attachment of monocytes to endothelial cells. J Bioenerg Biomembr. 2020;52(4):247–256. doi:10.1007/s10863-020-09841-9
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Clinical protocols for COVID-19 (The modified fifth and the sixth editions). Available from: http://www.nhc.gov.cn/xcs/zhengcwj/list_gzbd_6.shtml. Accessed February 8, 2020.
   Google Scholar
• Rieder M, Wirth L, Pollmeier L, et al. Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in coronavirus disease 2019. J Infect Dis. 2020;223(5):775–784. doi:10.1093/infdis/jiaa741
   Web of Science ®Google Scholar
• Vanderheiden A, Ralfs P, Chirkova T, et al. Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J Virol. 2020;94(19):e00985–20. doi:10.1128/JVI.00985-20
   PubMed Web of Science ®Google Scholar
• McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87–103. doi:10.1038/nri3787
   PubMed Web of Science ®Google Scholar
• Thurner L, Fadle N, Bewarder M, et al. Autoantibodies against progranulin and IL-1 receptor antagonist in critically ill COVID-19. bioRxiv. 2021:441188. doi:10.1101/2021.04.23.441188
   Google Scholar
• Brown BL, McCullough J. Treatment for emerging viruses: convalescent plasma and COVID-19. Transfus Apher Sci. 2020;59(3):20. doi:10.1016/j.transci.2020.102790
   Web of Science ®Google Scholar
• Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018;19(4):1057. doi:10.3390/ijms19041057
   PubMed Web of Science ®Google Scholar
• Kitani A, Nakashima N, Matsuda T, et al. T cells bound by vascular cell adhesion molecule-1/CD106 in synovial fluid in rheumatoid arthritis: inhibitory role of soluble vascular cell adhesion molecule-1 in T cell activation. J Immunol. 1996;156(6):2300–2308.
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Japar KV, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2021;41:110–119. doi:10.1016/j.ajem.2020.12.076
   PubMed Web of Science ®Google Scholar
• Kotela A, Wojdasiewicz P, Łęgosz P, et al. Increased serum levels of progranulin (PGRN) in patients with haemophilic arthropathy. Clin Exp Pharmacol Physiol. 2019;46(4):373–379. doi:10.1111/1440-1681.13054
   PubMed Web of Science ®Google Scholar
• Jian J, Konopka J, Liu C. Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol. 2013;93(2):199–208. doi:10.1189/jlb.0812429
   PubMed Web of Science ®Google Scholar
• Goyal A, Prasad R, Goel P, Pal A, Prasad S, Rani I. An integrated approach of the potential underlying molecular mechanistic paradigms of SARS-CoV-2-mediated coagulopathy. Indian J Clin Biochem. 2021;15:1–17.
   Google Scholar
• Tan Y, Zhang W, Zhu Z, et al. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19. Cell Discov. 2021;7(1):1–19. doi:10.1038/s41421-021-00274-1
   PubMed Web of Science ®Google Scholar
• Byrne GJ, Ghellal A, Iddon J, et al. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst. 2000;92(16):1329–1336. doi:10.1093/jnci/92.16.1329
   PubMed Web of Science ®Google Scholar
• Xie H, Kang YJ. Role of copper in angiogenesis and its medicinal implications. Curr Med Chem. 2009;16(10):1304–1314. doi:10.2174/092986709787846622
   PubMed Web of Science ®Google Scholar
• Toh H, Cao M, Daniels E, Bateman A. Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model. PLoS One. 2013;8(5):e64989. doi:10.1371/journal.pone.0064989
   PubMed Web of Science ®Google Scholar
• Myhre PL, Heck SL, Skranes JB, et al. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity: cardiac MRI 6 months after COVID-19. Am Heart J. 2021;13(21):00197.
   Google Scholar
• Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. doi:10.1001/jamacardio.2020.3557
   PubMed Web of Science ®Google Scholar
• Pour OB, Yahyavi Y, Karimi A, et al. Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients. Int J Infect Dis. 2021;25(21):053.
   Google Scholar
• Rani I, Goyal A, Bhatnagar M, et al. Potential molecular mechanisms of zinc- and copper-mediated antiviral activity on COVID-19. Nutr Res. 2021;92:109–128. doi:10.1016/j.nutres.2021.05.008
   PubMed Web of Science ®Google Scholar
• Skalny AV, Rink L, Ajsuvakova OP, et al. Zinc and respiratory tract infections: perspectives for COVID-19 (Review). Int J Mol Med. 2020;46(1):17–26.
   PubMed Web of Science ®Google Scholar
• Bui TM, Wiesolek HL, Sumagin R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leu Biol. 2020;108(3):787–799. doi:10.1002/JLB.2MR0220-549R
   PubMed Web of Science ®Google Scholar
• Stubert J, Szewczyk M, Spitschak A, Knoll S, Richter DU, Pützer BM. Adenoviral mediated expression of anti-inflammatory progranulin by placental explants modulates endothelial cell activation by decrease of ICAM-1 expression. Placenta. 2020;90:109–117. doi:10.1016/j.placenta.2019.12.018
   PubMed Web of Science ®Google Scholar
• Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317–1329. doi:10.1182/blood.2020007214
   PubMed Web of Science ®Google Scholar
• Neri T, Nieri D, Celi A. P-selectin blockade in COVID-19-related ARDS. Am J Physiol Lung Cell Mol Physiol. 2020;318(6):L1237–L1238. doi:10.1152/ajplung.00202.2020
   PubMed Web of Science ®Google Scholar